Allovir Inc ALVR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/27/22 EDT
3.76UNCH (UNCH)
Volume
1,489
Close
3.76quote price arrow up+0.15 (+4.16%)
Volume
244,224
52 week range
3.21 - 26.41
Loading...
  • Open3.64
  • Day High3.80
  • Day Low3.42
  • Prev Close3.61
  • 52 Week High26.41
  • 52 Week High Date10/01/21
  • 52 Week Low3.21
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap245.98M
  • Shares Out65.42M
  • 10 Day Average Volume0.49M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-70.94

KEY STATS

  • Open3.64
  • Day High3.80
  • Day Low3.42
  • Prev Close3.61
  • 52 Week High26.41
  • 52 Week High Date10/01/21
  • 52 Week Low3.21
  • 52 Week Low Date05/12/22
  • Market Cap245.98M
  • Shares Out65.42M
  • 10 Day Average Volume0.49M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-70.94

RATIOS/PROFITABILITY

  • EPS (TTM)-2.93
  • P/E (TTM)-1.29
  • Fwd P/E (NTM)-1.22
  • EBITDA (TTM)-181.511M
  • ROE (TTM)-70.84%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/04/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Allovir Inc

There is no recent news for this security.

Profile

MORE
AlloVir, Inc. is a late clinical-stage cell therapy company. The Company is engaged in developing allogeneic T-cell therapies to treat and prevent viral diseases. Its virus-specific T cell (VST) therapy platform enables to generate VSTs designed to restore immunity in patients with T cell deficiencies. Its product candidate includes Viralym-M (ALVR105), ALVR106, ALVR109, ALVR107 and ALVR108. Its lead product candidate, Viralym-M, is a multi- VST therapy targeting five...
David Hallal
Executive Chairman of the Board
Diana Brainard M.D.
Chief Executive Officer, Director
Vikas Sinha CPA
President, Chief Financial Officer, Director
Brett Hagen
Chief Accounting Officer
Edward Miller J.D.
General Counsel, Secretary
Address
1100 Winter Street
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
PRVB
Provention Bio Inc
4.08+0.18+4.62%
GRCL
Gracell Biotechnologies Inc
3.15+0.15+5.00%
ACIU
AC Immune SA
3.22-0.04-1.23%
LXRX
Lexicon Pharmaceuticals Inc
1.74+0.06+3.57%
VSTM
Verastem Inc
1.27+0.03+2.42%